Insmed
INSM
#748
Rank
A$47.89 B
Marketcap
A$224.59
Share price
-0.26%
Change (1 day)
78.77%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: A$47.89 Billion

As of February 2026 Insmed has a market cap of A$47.89 Billion. This makes Insmed the world's 748th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026A$47.89 B-15.43%
2025A$56.63 B182.89%
2024A$20.02 B207.67%
2023A$6.50 B63.6%
2022A$3.97 B-10.57%
2021A$4.44 B0.85%
2020A$4.41 B44.18%
2019A$3.05 B112.45%
2018A$1.43 B-52.93%
2017A$3.05 B169.34%
2016A$1.13 B-26.26%
2015A$1.54 B63.58%
2014A$0.94 B26.22%
2013A$0.74 B267.97%
2012A$0.20 B174.42%
2011A$73.86 M-24.01%
2010A$97.21 M-12.9%
2009A$0.11 B37.7%
2008A$81.05 M-29.54%
2007A$0.11 B1.7%
2006A$0.11 B-36.85%
2005A$0.17 B40.4%
2004A$0.12 B-16.85%
2003A$0.15 B480.07%
2002A$26.44 M-89.27%
2001A$0.24 B21.13%
2000A$0.20 B

End of Day market cap according to different sources

On Feb 23rd, 2026 the market cap of Insmed was reported to be:

A$48.53 Billion
by Nasdaq info icon info icon
A$48.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$457.38 B 854.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$259.35 B 441.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$175.32 B 266.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.79 B-94.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$1.06 B-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$2.32 B-95.16%๐Ÿ‡บ๐Ÿ‡ธ USA